However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose UDCA in patients with primary sclerosing cholangitis (PSC) may be harmful; adverse events ...

In this issue 2025 Summit standouts and shortfalls Can Angola advance African leadership as AU chair? Doing justice to the theme of 2025 Extended PSC tenures or rotational membership? Five years to ...